Skip to main content

Main menu

  • Home
  • Articles
    • Current
    • Published Ahead of Print
    • Archive
    • Supplemental Issues
    • Collections - French
    • Collections - English
  • Info for
    • Authors & Reviewers
    • Submit a Manuscript
    • Advertisers
    • Careers & Locums
    • Subscribers
    • Permissions
  • About CFP
    • About CFP
    • About the CFPC
    • Editorial Advisory Board
    • Terms of Use
    • Contact Us
  • Feedback
    • Feedback
    • Rapid Responses
    • Most Read
    • Most Cited
    • Email Alerts
  • Blogs
    • Latest Blogs
    • Blog Guidelines
    • Directives pour les blogues
  • Mainpro+ Credits
    • About Mainpro+
    • Member Login
    • Instructions
  • Other Publications
    • http://www.cfpc.ca/Canadianfamilyphysician/
    • https://www.cfpc.ca/Login/
    • Careers and Locums

User menu

  • My alerts

Search

  • Advanced search
The College of Family Physicians of Canada
  • Other Publications
    • http://www.cfpc.ca/Canadianfamilyphysician/
    • https://www.cfpc.ca/Login/
    • Careers and Locums
  • My alerts
The College of Family Physicians of Canada

Advanced Search

  • Home
  • Articles
    • Current
    • Published Ahead of Print
    • Archive
    • Supplemental Issues
    • Collections - French
    • Collections - English
  • Info for
    • Authors & Reviewers
    • Submit a Manuscript
    • Advertisers
    • Careers & Locums
    • Subscribers
    • Permissions
  • About CFP
    • About CFP
    • About the CFPC
    • Editorial Advisory Board
    • Terms of Use
    • Contact Us
  • Feedback
    • Feedback
    • Rapid Responses
    • Most Read
    • Most Cited
    • Email Alerts
  • Blogs
    • Latest Blogs
    • Blog Guidelines
    • Directives pour les blogues
  • Mainpro+ Credits
    • About Mainpro+
    • Member Login
    • Instructions
  • RSS feeds
  • Follow cfp Template on Twitter
  • LinkedIn
  • Instagram
OtherPractice

Stockpile, use during outbreaks, restock, repeat

Michael R. Kolber and Christina Korownyk
Canadian Family Physician February 2017; 63 (2) 134;
Michael R. Kolber
Associate Professor in the Department of Family Medicine at the University of Alberta in Edmonton.
MD CCFP MSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christina Korownyk
Associate Professor in the Department of Family Medicine at the University of Alberta in Edmonton.
MD CCFP
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • eLetters
  • Info & Metrics
  • PDF
Loading

Clinical question

How effective are oseltamivir and zanamivir for decreasing postexposure transmission of influenza?

Bottom line

For institutionalized seniors, 6 weeks of oseltamivir or 14 days of zanamivir will prevent 1 additional influenza case in every 25 to 27 patients treated. For every 7 to 8 households given postexposure prophylaxis (PEP), 1 household will avoid anyone developing influenza.

Evidence

Best evidence is from mostly unpublished, industry sponsored RCTs1 (1990s) and 2 systematic reviews.2,3 Results are based on laboratory-confirmed, symptomatic influenza.

  • Institutionalized seniors.

    • -Two RCTs examined zanamivir PEP during an influenza outbreak (10 cases or 10% with influenza) using 14 days of zanamivir (10 mg/d) versus rimantadine (N = 385, 98% vaccinated) or placebo (N = 489, 9% vaccinated).

      • —At 15 days 2.9% of those taking zanamivir had influenza versus 7.4% of those taking rimantadine (statistically significant); 6.3% of those taking zanamivir had influenza versus 9.2% for placebo (not significant).

      • —Pooled (by authors): 4.6% versus 8.3%; NNT = 27.

    • -A study of 6 weeks of oseltamivir (75 mg/d) or placebo in 548 (69% vaccinated) patients when influenza was “noted in the community” found influenza at 8 weeks in 0.3% of patients versus 4.4% for placebo; NNT = 25.

  • For households, 3 clustered (by household) RCTs examined PEP when a household member was diagnosed with influenza-like illness (mean age of contacts 24 to 33 years; < 15% vaccinated; children excluded).

    • -Zanamivir or placebo for 10 days: 4.6% of households had 1 or more new influenza cases at 11 days (pooled)1,4 versus 20.5% for placebo; NNT = 7.

    • -Oseltamivir (75 mg/d) or placebo for 7 days: 2.1% of households had 1 or more new influenza cases at 21 days1,5 versus 14.6% for placebo; NNT = 8.

  • There was no difference in hospitalizations.2,3 Multiple analyses were performed for adverse effects.3 For oseltamivir: psychiatric events (NNH = 95), headache (NNH= 32), and nausea (NNH = 25).2,3 For zanamivir: no difference in treatment trials.3 Limitations include inconsistent outcome definitions and selective reporting.2

Context

  • Canada stockpiles about 60 million doses (primarily oseltamivir); about 50% expire before use.6

  • In closed facility outbreaks, guidelines recommend treating the index case, vaccinating the unvaccinated,7 and PEP for the longer of 14 days or 7 days after the onset of symptoms in the last infected person.8 For households, PEP is recommended only if vaccination is contraindicated.7

Implementation

Antiviral PEP is not a substitute for influenza vaccination.8 Vaccine efficacy is determined by seasonal prevalence and vaccine matching. For every 13 long-term care residents vaccinated, 1 fewer will develop influenza.9 Evidence suggests vaccination of health care workers decreases long-term care residents’ mortality.10,11 While 72% of FPs reported being vaccinated, overall health care worker vaccination rates are about 50%.12 Institution outbreaks should be considered when 2 or more residents have influenza-like symptoms within 72 hours of one another.8

Acknowledgments

We thank Dr T. Jefferson for advising us of the location of the unpublished reports.

Notes

Tools for Practice

Tools for Practice articles in Canadian Family Physician (CFP) are adapted from articles published on the Alberta College of Family Physicians (ACFP) website, summarizing medical evidence with a focus on topical issues and practice-modifying information. The ACFP summaries and the series in CFP are coordinated by Dr G. Michael Allan, and the summaries are co-authored by at least 1 practising family physician and are peer reviewed. Feedback is welcome and can be sent to toolsforpractice{at}cfpc.ca. Archived articles are available on the ACFP website: www.acfp.ca.

Footnotes

  • Competing interests

    None declared

  • The opinions expressed in Tools for Practice articles are those of the authors and do not necessarily mirror the perspective and policy of the Alberta College of Family Physicians.

  • Copyright© the College of Family Physicians of Canada

References

  1. 1.↵
    1. Jefferson T,
    2. Jones MA,
    3. Doshi P,
    4. Del Mar CB,
    5. Hama R,
    6. Thompson MJ
    . Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children. Durham, NC: Dryad; 2014. Available from: http://dx.doi.org/10.5061/dryad.77471. Accessed 2016 Oct 14.
  2. 2.↵
    1. Jefferson T,
    2. Jones MA,
    3. Doshi P,
    4. Del Mar CB,
    5. Hama R,
    6. Thompson MJ,
    7. et al
    . Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children. Cochrane Database Syst Rev 2014;(4):CD008965.
  3. 3.↵
    1. Heneghan CJ,
    2. Onakpoya I,
    3. Jones MA,
    4. Doshi P,
    5. Del Mar CB,
    6. Hama R,
    7. et al
    . Neuraminidase inhibitors for influenza: a systematic review and meta-analysis of regulatory and mortality data. Health Technol Assess 2016;20(42):1-242.
    OpenUrlCrossRefPubMed
  4. 4.↵
    1. Hayden FG,
    2. Gubareva LV,
    3. Monto AS,
    4. Klein TC,
    5. Elliot MJ,
    6. Hammond JM,
    7. et al
    . Inhaled zanamivir for the prevention of influenza in families. N Engl J Med 2000;343:1282-9.
    OpenUrlCrossRefPubMed
  5. 5.↵
    1. Welliver R,
    2. Monto AS,
    3. Carewicz O,
    4. Schatteman E,
    5. Hassman M,
    6. Hedrick J,
    7. et al
    . Effectiveness of oseltamivir in preventing influenza in household contacts. JAMA 2001;285:748-54.
    OpenUrlCrossRefPubMed
  6. 6.↵
    Canadian pandemic influenza plan for the health sector. The use of antiviral drugs during a pandemic. Ottawa, ON: Public Health Agency of Canada; 2009. Available from: www.phac-aspc.gc.ca/cpip-pclcpi/assets/pdf/annex_e-eng.pdf. Accessed 2016 Oct 20.
  7. 7.↵
    1. Aoki FY,
    2. Allen UD,
    3. Stiver HG,
    4. Evans GA
    . The use of antiviral drugs for influenza: a foundation document for practitioners. Can J Infect Dis Med Microbiol 2013;24(Suppl C):1C-15C.
    OpenUrl
  8. 8.↵
    1. Harper SA,
    2. Bradley JS,
    3. Englund JA,
    4. File TM,
    5. Gravenstein S,
    6. Hayden FG,
    7. et al
    . Seasonal influenza in adults and children—diagnosis, treatment, chemoprophylaxis and institutional outbreak management: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis 2009;48:1003-32.
    OpenUrlCrossRefPubMed
  9. 9.↵
    1. Rudenko LG,
    2. Arden NH,
    3. Grigorieva E,
    4. Naychin A,
    5. Rekstin A,
    6. Klimov AI,
    7. et al
    . Immunogenicity and efficacy of Russian live attenuated and US inactivated influenza vaccines used alone and in combination in nursing home residents. Vaccine 2000;19:308-18.
    OpenUrlCrossRefPubMed
  10. 10.↵
    1. Ahmed F,
    2. Lindley MC,
    3. Allred N,
    4. Weinbaum CM,
    5. Grohskopf L
    . Effect of influenza vaccination of healthcare personnel on morbidity and mortality among patients: systematic review and grading of evidence. Clin Infect Dis 2014;58(1):50-7.
    OpenUrlCrossRefPubMed
  11. 11.↵
    1. Thomas RE,
    2. Jefferson T,
    3. Lasserson TJ
    . Influenza vaccination for healthcare workers who care for people aged 60 or older living in long-term care institutions. Cochrane Database Syst Rev 2016;(6):CD005187.
  12. 12.↵
    1. Buchan SA,
    2. Kwong JC
    . Influenza immunization among Canadian health care personnel: a cross-sectional study. CMAJ Open 2016;4(3):E479-88.
    OpenUrl
PreviousNext
Back to top

In this issue

Canadian Family Physician: 63 (2)
Canadian Family Physician
Vol. 63, Issue 2
1 Feb 2017
  • Table of Contents
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on The College of Family Physicians of Canada.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Stockpile, use during outbreaks, restock, repeat
(Your Name) has sent you a message from The College of Family Physicians of Canada
(Your Name) thought you would like to see the The College of Family Physicians of Canada web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Stockpile, use during outbreaks, restock, repeat
Michael R. Kolber, Christina Korownyk
Canadian Family Physician Feb 2017, 63 (2) 134;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Respond to this article
Share
Stockpile, use during outbreaks, restock, repeat
Michael R. Kolber, Christina Korownyk
Canadian Family Physician Feb 2017, 63 (2) 134;
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Clinical question
    • Bottom line
    • Evidence
    • Context
    • Implementation
    • Acknowledgments
    • Notes
    • Footnotes
    • References
  • eLetters
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Practice

  • Managing type 2 diabetes in primary care during COVID-19
  • Effectiveness of dermoscopy in skin cancer diagnosis
  • Spontaneous pneumothorax in children
Show more Practice

Tools for Practice

  • Testosterone supplementation for men
  • Time to challenge penicillin allergy labels
  • Antibiotics for acute diverticulitis
Show more Tools for Practice

Similar Articles

Navigate

  • Home
  • Current Issue
  • Archive
  • Collections - English
  • Collections - Française

For Authors

  • Authors and Reviewers
  • Submit a Manuscript
  • Permissions
  • Terms of Use

General Information

  • About CFP
  • About the CFPC
  • Advertisers
  • Careers & Locums
  • Editorial Advisory Board
  • Subscribers

Journal Services

  • Email Alerts
  • Twitter
  • LinkedIn
  • Instagram
  • RSS Feeds

Copyright © 2025 by The College of Family Physicians of Canada

Powered by HighWire